Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of 10 citing Brandstätter: Sex-specific association of the putative fructose transporter SLC2A9 variants.... (0.07 sec) 

SLC2A9--a fructose transporter identified as a novel uric acid transporter

- oxfordjournals.org
MPT Le, M Shafiu, W Mu, RJ Johnson - Nephrology Dialysis Transplantation, 2008 - ERA-EDTA
SLC2A9 was recently cloned and identified as a member of the SLC2A gene family of hexose
facilitative transporters, where its main physiological role was assumed to be in the transport
of glucose and fructose. However, new findings have unearthed a novel role for SLC2A9 ( ...
Cited by 6 - Related articles - All 5 versions

Mutations in the SLC2A9 gene cause hyperuricosuria and hyperuricemia in the …


D Bannasch, N Safra, A Young, N Karmi, RS … - PLoS …, 2008 - pubmedcentral.nih.gov
Allantoin is the end product of purine catabolism in all mammals except humans, great apes,
and one breed of dog, the Dalmatian. Humans and Dalmatian dogs produce uric acid during
purine degradation, which leads to elevated levels of uric acid in blood and urine and can ...
Cited by 4 - Related articles - All 6 versions

Crystal ball gazing: new therapeutic targets for hyperuricaemia and gout


N Dalbeth, T Merriman - Rheumatology, 2008 - Br Soc Rheumatology
Recent studies in diverse disciplines have led to significant advances in the understanding of
the basic biology of hyperuricaemia and gout, with important implications for future
treatment. These findings include genetic variation within SLC2A9 as a key regulator of ...
Cited by 5 - Related articles - All 9 versions

A common variant in the adiponutrin gene influences liver enzyme levels


B Kollerits, S Coassin, S Kiechl, SC Hunt, B … - British Medical …, 2009 - jmg.bmj.com
Online First articles must include the digital object identifier (DOIs) and date of initial
publication. establish publication priority; they are indexed by PubMed from initial
publication. Citations to may be posted when available prior to final publication). Online ...
Cited by 1 - Related articles - All 2 versions

Role of the urate transporter SLC2A9 gene in susceptibility to gout in New Zealand …


JE Hollis-Moffatt, X Xu, N Dalbeth, ME … - Arthritis Care & … - interscience.wiley.com
It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ...

Genetic influence on variation in serum uric acid in American Indians: the strong …


VS Voruganti, HHH Göring, A Mottl, N Franceschini, K … - Human Genetics - Springer
Abstract Hyperuricemia is associated with the metabolic syndrome, gout, renal and cardiovascular
disease (CVD). American Indians have high rates of CVD and 25% of individuals in the strong
heart family study (SHFS) have high serum uric acid levels. The aim of this study was to ...
Related articles - All 2 versions

Facilitative glucose transporter 9, a unique hexose and urate transporter


M Doblado, KH Moley - American Journal of Physiology- …, 2009 - Am Physiological Soc
GLUT9 is a novel, facilitative glucose transporter isoform that exists as two alternative splice
variants encoding two proteins that differ in their NH 2 -terminal sequence (GLUT9a and
GLUT9b). Both forms of GLUT9 protein and mRNA are expressed in the epithelia of ...
Related articles - All 4 versions

[PDF] Novel therapies for treatment of gout and hyperuricemia


R Terkeltaub - Arthritis Research & Therapy, 2009 - arthritis-research.com
In the past few decades, gout has increased not only in prevalence, but also in clinical
complexity, the latter accentuated in part by a dearth of novel advances in treatments for hyperuricemia
and gouty arthritis. Fortunately, recent research reviewed here, much of it founded on ...
Related articles - View as HTML - All 3 versions

Managing Gout--From Acute Relief to Long-term Control CME/CE


N Schlesinger - medscape.com
Although the term "gout" was not used until the 12 th century, the condition has been recorded
since antiquity, with the ancient Egyptians first describing it in 2500 BC, and Hippocrates calling
it "the unwalkable disease" around 600 BC. [1] There have been many further reports of ...
Related articles

Mouse GLUT9: evidences for a urate uniporter


S Bibert, K Hess… - American Journal of Physiology- Renal …, 2009 - Am Physiological Soc
Page 1. 1 Mouse GLUT9: evidences for a urate uniporter 1 2 Stéphanie Bibert 1 ,
Solange Kharoubi Hess 1 , Dmitri Firsov 1 , Bernard Thorens 2 , Käthi 3 Geering 1 ,
Jean-Daniel Horisberger 1,† , Olivier Bonny 1 4 5 1. Department ...
Related articles - All 3 versions


 


Go to Google Home - About Google - About Google Scholar

©2009 Google